BRIEF-Fitch Expects European Insurance M&A To Accelerate In 2026-March 2024-www.financetom.com

BRIEF-Fitch Expects European Insurance M&A To Accelerate In 2026

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Fitch Expects European Insurance M&A To Accelerate In 2026

Mar 11, 2026 4:14 AM

Feb 16 (Reuters) - Fitch:

* ‌FITCH: ⁠EUROPEAN ⁠INSURANCE ‌M&A ‌TO ACCELERATE ‌IN 2026

* FITCH: EXPECT ‌INCREASED M&A ⁠ACTIVITY ⁠IN ⁠SPECIALTY ‌AND

REINSURANCE, ‌UK, ⁠DUTCH AND GERMAN LIFE, ‌AND EUROPEAN

BANCASSURANCE

Previous page： EBay wants newsletter publishers its employees harassed to ID sources Next page： --RH Guides For FY 2024 Revenue Growth of 5%-7%; Sees Q3 Revenue Growth of 7%-9%

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

EBay wants newsletter publishers its employees harassed to ID sources

Sep 12, 2024

BOSTON, Sept 12 (Reuters) - EBay has asked a judge to force the publishers of an e-commerce newsletter to disclose the identity of their news sources so it can defend itself against a lawsuit they filed after several of the company's employees admitted to carrying out a bizarre campaign to harass and terrorize them. The e-commerce company in a motion...

--RH Guides For FY 2024 Revenue Growth of 5%-7%; Sees Q3 Revenue Growth of 7%-9%

Sep 12, 2024

04:11 PM EDT, 09/12/2024 (MT Newswires) -- Price: 299.00, Change: +42.23, Percent Change: +16.45 ...

Champion Homes Insider Sold Shares Worth $2,596,023, According to a Recent SEC Filing

Sep 12, 2024

03:53 PM EDT, 09/12/2024 (MT Newswires) -- Mark J. Yost, Director, CEO & President, on September 10, 2024, sold 30,000 shares in Champion Homes ( SKY ) for $2,596,023. Following the Form 4 filing with the SEC, Yost has control over a total of 400,606 shares of the company, with 197,327 shares held directly and 203,279 controlled indirectly. SEC Filing:...

BioNexus Gene Lab, Chenzhen Rongguang Health Group Partner to Expand Cancer Screening

Sep 12, 2024

01:42 PM EDT, 09/12/2024 (MT Newswires) -- BioNexus Gene Lab ( BGLC ) plans to partner with Chenzhen Rongguang Health Group to expand cancer screening and diagnostic tools in Southeast Asia and China. The collaboration includes research and development of exosome therapy and regenerative medicine, BioNexus said Thursday in a statement. Price: 0.49, Change: +0.14, Percent Change: +38.78 ...